H. Lundbeck A/S (HLUYY): Price and Financial Metrics
HLUYY Price/Volume Stats
| Current price | $22.00 | 52-week high | $31.55 |
| Prev. close | $22.01 | 52-week low | $10.00 |
| Day low | $22.00 | Volume | 7,500 |
| Day high | $24.00 | Avg. volume | 1,758 |
| 50-day MA | $21.27 | Dividend yield | 0.89% |
| 200-day MA | $24.97 | Market Cap | 21.91B |
HLUYY Stock Price Chart Interactive Chart >
H. Lundbeck A/S (HLUYY) Company Bio
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for treating symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; and Rexulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. H. Lundbeck A/S has research collaboration with Enamine Ltd. The company was founded in 1915 and is headquartered in Valby, Denmark.
HLUYY Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -15.43% |
| 5-year | -39.16% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -25.66% |
| 2020 | -9.31% |
| 2019 | -10.55% |
HLUYY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Loading social stream, please wait...